HISTONDEMETHYLASE-INHIBITOREN

Patent europeic · EP2970211 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2970211
Numer da la dumonda
EP14768099
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
12-03-2014
Publitgà
20-01-2016
Concedì
26-07-2017
Stritgà
23-10-2024
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 471/04 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201361791406 P 15.03.2013
Dumonda PCT
PCT/US2014/024998 12.03.2014
Publicaziun PCT
WO2014/151106 25.09.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-10-2024

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2024

  2. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  3. 13-09-2019

    Transferì

    Owner
    Quanticel Pharmaceuticals Inc, 9393 Towne Centre Drive, Suite 110, San Diego, CA 92121, USA → Celgene Quanticel Research, Inc., 9393 Towne Centre Drive, San Diego, CA 92121, USA

    Published in Swissreg on 13.09.2019

  4. 03-10-2017

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 03.10.2017

  5. 26-07-2017

    Concedì

    Published in Swissreg on 26.07.2017

Partidas

Inventur

KANOUNI, Toufike

San Diego, CA 92121, US

STAFFORD, Jeffrey Alan

San Diego, CA 92130, US

VEAL, James Marvin

Apex, NC 27502, US

WALLACE, Michael Brennan

San Diego, CA 92117, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.